1. "BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION": NEITHER BURKITT-LYMPHOMA NOR DIFFUSE LARGE B-CELL LYMPHOMA. WHAT THE MICROENVIRONMENT TELLS US. (October 2022) Authors: Del Corvo, M.; Sapienza, M.; Siciliano, M.; Tornambè, S.; Mazzara, S.; Granai, M.; Mundo, L.; Arcuri, F.; Mancini, V.; Ferrara, D.; Ott, G.; Siebert, Reiner; Fend, L. Quintanilla; Fend, F.; Pileri, S.; Lazzi, S.; Leoncini, L. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. "Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia". (2017) Authors: Cavallari, Maurizio; Ciccone, Maria; Falzoni, Simonetta; Cavazzini, Francesco; Formigaro, Luca; Di Virgilio, Francesco; Rotola, Antonella; Rigolin, Gian Matteo; Cuneo, Antonio Journal: Leukemia research reports Issue: Volume 7(2017) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. "Preleukemic or smoldering" chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report. Issue 1 (2015) Authors: Bennett, John M.; Dsouza, Kevin G.; Patel, Mehul; O'Dwyer, Kristen Journal: Leukemia research reports Issue: Volume 4:Issue 1(2015) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. "Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese". Issue 3 (March 2015) Authors: Mele, G.; Melpignano, A.; Quarta, G.; Palumbo, G.; Capalbo, S.; Falcone, A.; Cascavilla, N.; Palazzo, G.; Mazza, P.; Iannitto, E.; Curci, P.; Rizzi, R.; Specchia, G.; Rossini, B.; Pavone, V.; Ria, R.; Vacca, A.; Buquicchio, C.; Tarantini, G.; Minoia, C. Journal: Leukemia research Issue: Volume 39:Issue 3(2015:Mar.) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. "Reversible" myelodysplastic syndrome or ineffectual clonal haematopoiesis? – add(6p) myeloid neoplasm with a spontaneous cytogenetic remission. (October 2018) Authors: Rady, K.; Blombery, P.; Westerman, D.A.; Wall, M.; Curtis, M.; Campbell, L.J.; Seymour, J.F. Journal: Leukemia research Issue: Volume 73(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1 GENOMICS AND EPIGENOMICS. (April 2015) Authors: Figueroa, M.E. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 1, 25-OH2 vitamin D3 and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL). (2018) Authors: Pistor, Maximilian; Schrewe, Lisa; Haupeltshofer, Steffen; Miclea, Andrei; Faissner, Simon; Chan, Andrew; Hoepner, Robert Journal: Leukemia research reports Issue: Volume 9(2018) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 10 OVERLAP SYNDROMES INCLUDING CMMOL. (April 2015) Authors: Padron, E. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 10-year nationwide trends in incidence, treatment patterns, and mortality of patients with myelodysplastic syndromes in Denmark. (May 2023) Authors: Lauritsen, Tine Bichel; Nørgaard, Jan Maxwell; Dalton, Susanne Oksbjerg; Grønbæk, Kirsten; El-Galaly, Tarec Christoffer; Østgård, Lene Sofie Granfeldt Journal: Leukemia research Issue: Volume 128(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 100 INTERNATIONAL, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH IPSS INTERMEDIATE-1 MYELODYSPLASTIC SYNDROMES WITH RBC-TRANSFUSION-DEPENDENT ANEMIA AND THROMBOCYTOPENIA: THE QUAZAR LOWER-RISK MDS TRIAL. Issue 1 (April 2015) Authors: Garcia-Manero, G.; Platzbecker, U.; Santini, V.; Voso, M.T.; Garcia, R.; Valcarcel, D.; Silverman, L.R.; Almeida, A.; Giagounidis, A.; Larsen, S.R.; Kreitz, S.; Hoenekopp, A.; Skikne, B.S. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗